On Tuesday, Axsome Therapeutics Inc (NASDAQ: AXSM) opened lower -4.25% from the last session, before settling in for the closing price of $116.63. Price fluctuations for AXSM have ranged from $64.11 to $139.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 96.67% over the last five years. Company’s average yearly earnings per share was noted 47.62% at the time writing. With a float of $40.08 million, this company’s outstanding shares have now reached $48.67 million.
The firm has a total of 683 workers. Let’s measure their productivity. In terms of profitability, gross margin is 90.89%, operating margin of -73.11%, and the pretax margin is -74.45%.
Axsome Therapeutics Inc (AXSM) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Axsome Therapeutics Inc is 17.82%, while institutional ownership is 77.69%. The most recent insider transaction that took place on Feb 13 ’25, was worth 1,558,320. In this transaction Chief Financial Officer of this company sold 12,000 shares at a rate of $129.86, taking the stock ownership to the 42,187 shares. Before that another transaction happened on Feb 14 ’25, when Company’s Chief Financial Officer sold 3,000 for $131.07, making the entire transaction worth $393,210. This insider now owns 42,187 shares in total.
Axsome Therapeutics Inc (AXSM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 47.62% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Check out the current performance indicators for Axsome Therapeutics Inc (AXSM). In the past quarter, the stock posted a quick ratio of 2.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.00, a number that is poised to hit -1.30 in the next quarter and is forecasted to reach 2.35 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Analysing the last 5-days average volume posted by the [Axsome Therapeutics Inc, AXSM], we can find that recorded value of 0.8 million was lower than the volume posted last year of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 15.42%. Additionally, its Average True Range was 5.09.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 56.80%, which indicates a significant increase from 20.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.07% in the past 14 days, which was lower than the 55.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $119.77, while its 200-day Moving Average is $96.32. Now, the first resistance to watch is $114.60. This is followed by the second major resistance level at $117.54. The third major resistance level sits at $121.34. If the price goes on to break the first support level at $107.87, it is likely to go to the next support level at $104.07. Should the price break the second support level, the third support level stands at $101.13.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
There are currently 48,765K shares outstanding in the company with a market cap of 5.45 billion. Presently, the company’s annual sales total 385,690 K according to its annual income of -287,220 K. Last quarter, the company’s sales amounted to 118,770 K and its income totaled -74,910 K.
